Anticancer drug targets: growth factors and growth factor signaling

被引：121

作者：

Gibbs, JB ^{[1
]}

机构：

[1] Merck Sharp & Dohme Ltd, Dept Canc Res, Wp16 101 Canc Res, West Point, PA 19486 USA

来源：

JOURNAL OF CLINICAL INVESTIGATION | 2000年 / 105卷 / 01期

关键词：

D O I：

10.1172/JCI9084

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

[No abstract available]

引用

页码：9 / 13

页数：5

共 34 条

[1]

[Anonymous], 1997, BIOCH BIOPHYSICA ACT

[2]

Baselga J, 1999, SEMIN ONCOL, V26, P78

[3]

Baselga J, 1998, CANCER RES, V58, P2825

[4]

Du W, 1999, CANCER RES, V59, P4208

[5] Phase I and pharmacologic study of the tyrosine kinase inhibitor SU101 in patients with advanced solid tumors [J].

Eckhardt, SG ;

Rizzo, J ;

Sweeney, KR ;

Cropp, G ;

Baker, SD ;

Kraynak, MA ;

Kuhn, JG ;

Villalona-Calero, MA ;

Hammond, L ;

Weiss, G ;

Thurman, A ;

Smith, L ;

Drengler, R ;

Eckardt, JR ;

Moczygemba, J ;

Hannah, AL ;

Von Hoff, DD ;

Rowinsky, EK .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (04) :1095-1104

[6]

Ewer MS, 1999, SEMIN ONCOL, V26, P96

[7]

Fan Zhen, 1998, Current Opinion in Oncology, V10, P67, DOI 10.1097/00001622-199801000-00011

[8] Identification of a novel inhibitor of mitogen-activated protein kinase kinase [J].

Favata, MF ;

Horiuchi, KY ;

Manos, EJ ;

Daulerio, AJ ;

Stradley, DA ;

Feeser, WS ;

Van Dyk, DE ;

Pitts, WJ ;

Earl, RA ;

Hobbs, F ;

Copeland, RA ;

Magolda, RL ;

Scherle, PA ;

Trzaskos, JM .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (29) :18623-18632

[9] Promising new developments in cancer chemotherapy [J].

Ferrante, K ;

Winograd, B ;

Canetta, R .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 43 (Suppl 1) :S61-S68

[10] Analogs of staurosporine: Potential anticancer drugs? [J].

Gescher, A .

GENERAL PHARMACOLOGY, 1998, 31 (05) :721-728

← 1 2 3 4 →